InnovAge Holding Corp. reports developments tied to its Program of All-inclusive Care for the Elderly (PACE) healthcare delivery platform for frail, predominantly dual-eligible seniors. The company provides comprehensive, capitated care intended to support older adults in home and community settings while managing use of hospitals, emergency rooms, and nursing homes.
Recurring news includes fiscal-quarter results, revenue and Adjusted EBITDA guidance, census and Total Member Months metrics, center performance, investments in clinical teams, technology and quality capabilities, and interactions with policymakers around the PACE model. Company updates also cover board composition, investor presentations, conference participation, and operating execution across its PACE centers.
InnovAge Holding Corp. (INNV) priced a secondary public offering of 10,000,000 shares of common stock by selling stockholders at $9.25 per share. The transaction, by funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe, is expected to close on September 24, 2026, subject to customary closing conditions.
The selling stockholders granted underwriters a 30-day option to buy up to an additional 1,500,000 shares at the public offering price, less underwriting discounts and commissions. InnovAge is not selling shares and will not receive proceeds, but will bear offering costs other than underwriting discounts and commissions. Barclays, Goldman Sachs & Co. LLC and Wells Fargo Securities lead the underwriting syndicate.
InnovAge Holding Corp (INNV) announced that investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe have launched an underwritten public secondary offering of 10,000,000 shares of InnovAge common stock as selling stockholders.
The selling stockholders also expect to grant underwriters a 30‑day option to purchase up to an additional 1,500,000 shares at the public offering price, less underwriting discounts and commissions. InnovAge is not issuing new shares and will not receive proceeds from the sale, but will bear offering-related costs other than underwriting discounts and commissions. Barclays, Goldman Sachs & Co. LLC and Wells Fargo Securities are joint book‑running managers, and the offering is being made under an effective shelf registration statement on Form S‑3.
InnovAge (INNV) reported fiscal 2026 results showing double‑digit revenue growth and a near break‑even bottom line for the year ended June 30, 2026.
Total revenue was $989.7 million, up 15.9% from $853.7 million in 2025. Income before income taxes was $0.3 million versus a $34.0 million loss, and net loss narrowed to $0.7 million from $35.3 million, with net loss margin improving to 0.1% from 4.1%. Net loss attributable to InnovAge was $2.5 million, or $0.02 per share, versus a $30.3 million loss, or $0.22 per share.
Center-level Contribution Margin rose to $227.8 million (23.0% of revenue) from $153.6 million (18.0%), while Adjusted EBITDA increased to $94.6 million (9.6% margin) from $34.5 million (4.0%). Participant census grew to about 8,230 and member months to about 96,050.
For fiscal 2027, InnovAge guides to revenue of $1.05–$1.085 billion, Adjusted EBITDA of $105–$115 million, census of 8,625–8,850 and total member months of 101,000–102,500.
InnovAge (Nasdaq: INNV) will release its fiscal 2026 fourth quarter and full-year financial results on Tuesday, September 8, 2026, after market close, followed by a conference call at 5:00 p.m. ET. Management will also present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026 at 8:00 a.m. ET, with both events webcast via the company’s investor relations website.
InnovAge (Nasdaq: INNV) appointed Jennifer Browne as President and Chief Operating Officer, effective June 8, 2026. She will oversee market operations and core support functions, focusing on execution, participant experience, and operational and compliance metrics.
Browne previously led value-based care operations at Strive Health and Optum. InnovAge’s PACE model serves about 8,050 participants across 20 centers in six states as of March 31, 2026.
InnovAge (Nasdaq: INNV) reported fiscal Q3 2026 results for the quarter ended March 31, 2026. Total revenues were $251.9M, up ~15.5% year-over-year. Adjusted EBITDA rose to $30.5M and Center-level Contribution Margin reached $61.0M. The company reported a net loss of $29.9M and ended the quarter with $95.5M cash and $43.1M short-term investments.
InnovAge raised full-year 2026 revenue guidance to $950–$975M and Adjusted EBITDA guidance to $85–$90M while keeping census guidance unchanged.
InnovAge (Nasdaq: INNV) will release its fiscal third quarter 2026 financial results on Tuesday, May 5, 2026 after market close and will host a conference call at 5:00 p.m. ET that day.
A live audio webcast will be available at the company's investor website, with a replay posted shortly after the call and available for a limited time. Phone access requires registration for a unique PIN; participants are encouraged to dial in 15 minutes early.
As of December 31, 2025, InnovAge served approximately 8,010 participants across 20 centers in six states.
InnovAge (Nasdaq: INNV) leaders, participants and partner LeadingAge Colorado met lawmakers at the Colorado State Capitol on February 5, 2026 to advocate for protecting and strengthening PACE and community-based senior care.
Participants emphasized PACE’s person-centered model, lower hospitalization and nursing home admission rates, caregiver relief, and the need for greater public awareness and supportive Medicaid and workforce policies.
InnovAge (Nasdaq: INNV) reported fiscal Q2 ended December 31, 2025 results showing revenue of $239.7M (+14.7% YoY) and net income of $11.8M versus a loss in prior-year quarter. Adjusted EBITDA was $22.2M and center-level contribution margin was $52.8M (22.0% of revenue).
The company raised fiscal 2026 revenue and Adjusted EBITDA guidance to a range of $925M–$950M and $70M–$75M, while full-year ending census guidance stayed at 7,900–8,100 members.
InnovAge (Nasdaq: INNV) announced the appointment of Pavithra Mahesh and Sean Traynor to its Board of Directors, effective January 29, 2026. The Board expands from nine to eleven directors; Mahesh joins the Quality and Compliance Committee and Traynor joins the Compensation, Nominating and Governance Committee. As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states.